Jeffrey H Becker

4PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 13, 2026
Resistance to the KRASG12D Inhibitor MRTX1133 Is Associated with Increased Sensitivity to BET Inhibition.

Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos

|Aug 20, 2024
Trametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells.

Thao D Pham, Anastasia E Metropulos, Nida Mubin

|Aug 13, 2024
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.

Jeffrey H Becker, Anastasia E Metropulos, Christina Spaulding

|May 13, 2022
Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies.

Qiyue Luan, Jeffrey H Becker, Celine Macaraniag

Pageof 1